Stocks In Play

(MENAFN- Baystreet) ATS Corporation
5/16/2024 10:08 AM EST

  • Oncolytics Biotech Inc
    5/16/2024 9:22 AM EST
  • Microbix Biosystems Inc.
    5/15/2024 11:54 AM EST
  • Northwest Healthcare Properties Real Estate Invest
    5/15/2024 10:35 AM EST
  • Chartwell Retirement Residences
    5/15/2024 10:28 AM EST
  • Thomson Reuters
    5/15/2024 10:06 AM EST
  • Probe Gold Inc.
    5/15/2024 10:00 AM EST
  • Obsidian Energy Ltd.
    5/15/2024 9:57 AM EST
  • Intermap Technologies
    5/15/2024 9:51 AM EST
  • Bridgemarq Real Estate Services Inc.
    5/15/2024 9:47 AM EST Previous Articles Subscribe to Get Small Cap News & Alerts Baystreet Staf - Thursday, May 16, 2024

    Stocks in Play

    5/16/2024 - 9:26 AM EST - Avant Technologies Inc : Announced an ambitious plan to develop a cutting-edge, proprietary AI software platform to power its next-generation data centers. This advanced platform will leverage machine learning algorithms to analyze data, predict resource needs, and make real-time resource allocation decisions, ushering in a new era of intelligent and autonomous data center management. Avant Technologies Inc shares O are trading unchanged at $0.97.

    Full Press Release:

    • About Us
    • Contact Us
    • Advertise
    • License Our Content
    • Jobs
    • Disclaimer
    • Privacy Policy

    Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks



    Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.